{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:31:33Z","timestamp":1791772293025,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejps.2023.106654","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T11:38:13Z","timestamp":1700912293000},"page":"106654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-3658","authenticated-orcid":false,"given":"Nasser","family":"Alhajj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Fakharul Zaman Raja","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall J.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cathcart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106654_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.supflu.2017.06.010","article-title":"Micronization of N-acetylcysteine by supercritical fluid: evaluation of in vitro and in vivo biological activity","volume":"130","author":"Aguiar","year":"2017","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.ejps.2023.106654_bib0002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41522-020-00138-8","article-title":"The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance","volume":"6","author":"Ahmed","year":"2020","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.ejps.2023.106654_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123151","article-title":"Quality by design \u2013 spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation","volume":"642","author":"Alhajj","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121657","article-title":"Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system","volume":"618","author":"Alhajj","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0005","article-title":"Developing ciprofloxacin dry powder for inhalation: a story of challenges and rational design in the treatment of cystic fibrosis lung infection","volume":"613","author":"Alhajj","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0006","series-title":"Sax\u2019s Dangerous Properties of Industrial Materials","year":"2012"},{"key":"10.1016\/j.ejps.2023.106654_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118543","article-title":"Dry powder formulation for pulmonary infections: ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray","volume":"273","author":"Arauzo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2023.106654_bib0008","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1165\/rcmb.2008-0338OC","article-title":"Quercetin stimulates Na+\/K+\/2Cl- cotransport via PTK-dependent mechanisms in human airway epithelium","volume":"41","author":"Asano","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejps.2023.106654_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00735-20","article-title":"Genotypic and phenotypic diversity of staphylococcus aureus isolates from cystic fibrosis patient lung infections and their interactions with Pseudomonas aeruginosa","volume":"11","author":"Bernardy","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ejps.2023.106654_bib0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s11095-017-2235-y","article-title":"Predicting pulmonary pharmacokinetics from in vitro properties of dry powder inhalers","volume":"34","author":"Bhagwat","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106654_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejps.2016.11.011","article-title":"In vitro biopharmaceutical evaluation of ciprofloxacin\/metal cation complexes for pulmonary administration","volume":"97","author":"Brillault","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106654_bib0012","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/17425247.2021.1886074","article-title":"Inhaled fixed-dose combination powders for the treatment of respiratory infections","volume":"18","author":"Brunaugh","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2023.106654_bib0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G","article-title":"Energy\/temperature diagram and compression behavior of the polymorphs of D-mannitol","volume":"89","author":"Burger","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106654_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2014.08.029","article-title":"Physicochemical characterization of D-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region","volume":"475","author":"Cares-Pacheco","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12248-019-0315-0","article-title":"Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of Pseudomonas aeruginosa biofilm isolated from cystic fibrosis and wound patients","volume":"21","author":"Chang","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2023.106654_bib0016","series-title":"Adsorption: Fundamental Processes and Applications","first-page":"629","article-title":"Chapter 10 - membrane adsorption","author":"Changmai","year":"2021"},{"key":"10.1016\/j.ejps.2023.106654_bib0017","article-title":"Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis: clofazimine inhaled formulation for tuberculosis","volume":"58","author":"de Castro","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2023.106654_bib0018","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/pharmaceutics14122667","article-title":"Dissolution and absorption of inhaled drug particles in the lungs","volume":"14","author":"Eedara","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106654_bib0019","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2022. EUCAST: Clinical breakpoints and dosing of antibiotics [WWW Document]. Eur. Comm. Antimicrob. Susceptibility Test. URL https:\/\/www.eucast.org\/clinical_breakpoints (accessed 11.30.23)."},{"key":"10.1016\/j.ejps.2023.106654_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphar.2016.00181","article-title":"Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds","volume":"7","author":"Fr\u00f6hlich","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106654_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ejps.2023.106654_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01297-2018","article-title":"Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH","volume":"52","author":"Hill","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejps.2023.106654_bib0023","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/pharmaceutics13111910","article-title":"Thermo-analytical and compatibility study with mechanistic explanation of degradation kinetics of ambroxol hydrochloride tablets under non-isothermal conditions","volume":"13","author":"Jeli\u0107","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106654_bib0024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/pharmaceutics10030098","article-title":"Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery","volume":"10","author":"Karagianni","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106654_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-021-02707-w","article-title":"Challenges of antibiotic resistance biofilms and potential combating strategies: a review","volume":"11","author":"Khan","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejps.2023.106654_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2020.10.010","article-title":"Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles","volume":"157","author":"Lababidi","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2019.10.038","article-title":"Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis","volume":"314","author":"Lababidi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106654_bib0028","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jps.23874","article-title":"Steroid-decorated antibiotic microparticles for inhaled anti-infective therapy","volume":"103","author":"Lee","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106654_bib0029","first-page":"12","article-title":"Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance","author":"Liao","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejps.2023.106654_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122550","article-title":"Development of spray-dried N-acetylcysteine dry powder for inhalation","volume":"631","author":"Mancini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the most critical pathogens","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejps.2023.106654_bib0032","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2019.02.018","article-title":"Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections","volume":"561","author":"Mangal","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118504","article-title":"Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants","volume":"568","author":"Mangal","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/gels7040243","article-title":"Ambroxol hydrochloride loaded gastro-retentive nanosuspension gels potentiate anticancer activity in lung cancer (A549) cells","author":"Md","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.ejps.2023.106654_bib0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11274-019-2719-5","article-title":"An overview on anti-biofilm properties of quercetin against bacterial pathogens","volume":"35","author":"Memariani","year":"2019","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejps.2023.106654_bib0036","doi-asserted-by":"crossref","first-page":"1B","DOI":"10.1002\/9780471729259.mc01b01s22","article-title":"Growing and analyzing static biofilms","volume":"22","author":"Merritt","year":"2011","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ejps.2023.106654_bib0037","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1021\/acs.cgd.6b01283","article-title":"Two faces of ciprofloxacin: investigation of proton transfer in solid state transformations","volume":"16","author":"Mesallati","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2023.106654_bib0038","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jam.13073","article-title":"Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa","volume":"120","author":"Ouyang","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejps.2023.106654_bib0039","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1074\/jbc.M116.770552","article-title":"Flavonoids suppress Pseudomonas aeruginosa virulence through allosteric inhibition of quorum-sensing receptors","volume":"292","author":"Paczkowski","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106654_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2023.106654_bib0041","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00441781","article-title":"A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis","volume":"144","author":"Ratjen","year":"1985","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ejps.2023.106654_bib0042","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1111\/j.2042-7158.1969.tb08344.x","article-title":"The effect of particle shape on powder properties","volume":"21","author":"Ridgway","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106654_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2020.137372","article-title":"Probing host-guest inclusion complexes of ambroxol hydrochloride with \u03b1- & \u03b2-cyclodextrins by physicochemical contrivance subsequently optimized by molecular modeling simulations","volume":"748","author":"Roy","year":"2020","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejps.2023.106654_bib0044","doi-asserted-by":"crossref","DOI":"10.1177\/1179550618821930","article-title":"Mucoactive agents in the therapy of upper respiratory airways infections: fair to describe them just as mucoactive?","volume":"12","author":"Scaglione","year":"2019","journal-title":"Clin. Med. Insights. Ear Nose Throat"},{"key":"10.1016\/j.ejps.2023.106654_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT170210P6","article-title":"Optimization of an in vitro dissolution test method for inhalation formulations","volume":"17","author":"Son","year":"2010","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ejps.2023.106654_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118653","article-title":"The effect of co-amorphization of glibenclamide on its dissolution properties and permeability through an MDCKII-MDR1 cell layer","volume":"570","author":"Sormunen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(98)00008-6","article-title":"Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro","volume":"7","author":"Srichana","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106654_bib0048","author":"Taghavi"},{"key":"10.1016\/j.ejps.2023.106654_bib0049","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hrtlng.2018.09.010","article-title":"Mucoactive agents for adults with acute lung conditions: a systematic review","volume":"48","author":"Tarrant","year":"2019","journal-title":"Hear. Lung"},{"key":"10.1016\/j.ejps.2023.106654_bib0050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpb.2013.03.020","article-title":"Steroid\/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery","volume":"85","author":"Tewes","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2023.106654_bib0051","series-title":"Ciprofloxacin, in: StatPearls","author":"Thai","year":"2021"},{"key":"10.1016\/j.ejps.2023.106654_bib0052","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cbin.10146","article-title":"The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells","volume":"37","author":"Varelogianni","year":"2013","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejps.2023.106654_bib0053","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jmii.2014.03.012","article-title":"Anti-quorum sensing activity of flavonoid-rich fraction from Centella asiatica L. against Pseudomonas aeruginosa PAO1","volume":"49","author":"Vasavi","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ejps.2023.106654_bib0054","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/lam.13129","article-title":"Anti-biofilm and cytoprotective activities of quercetin against Pseudomonas aeruginosa isolates","volume":"68","author":"Vipin","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.ejps.2023.106654_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4315\/0362-028X.JFP-17-214","article-title":"Bacteriostatic effect of quercetin as an antibiotic alternative in vivo and its antibacterial mechanism in vitro","volume":"81","author":"Wang","year":"2018","journal-title":"J. Food Prot."},{"key":"10.1016\/j.ejps.2023.106654_bib0056","article-title":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement","volume":"M100-S20","author":"Wayne","year":"2010","journal-title":"CLSI Doc"},{"key":"10.1016\/j.ejps.2023.106654_bib0057","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/46.5.669","article-title":"Application of fluoroquinolone pharmacodynamics","volume":"46","author":"Wright","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2023.106654_bib0058","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/js970224o","article-title":"Determination of the glass properties of D-mannitol using sorbitol as an impurity","volume":"87","author":"Yu","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106654_bib0059","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2500\/ajra.2011.25.3643","article-title":"Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis","volume":"25","author":"Zhang","year":"2011","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.ejps.2023.106654_bib0060","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1080\/22221751.2021.1994355","article-title":"Real-time monitoring of Pseudomonas aeruginosa biofilm growth dynamics and persister cells\u2019 eradication","volume":"10","author":"\u017diemyt\u0117","year":"2021","journal-title":"Emerg. Microbes Infect."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872300283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872300283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:12:30Z","timestamp":1760530350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872300283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":60,"alternative-id":["S092809872300283X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106654","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106654"}}